A single patient with metastatic (stage IV) melanoma treated with combination ipilimumab (anti‐CTLA‐4) and nivolumab (anti‐PD‐1) had serial blood draws prior to and during the course of treatment. The gene discussed is PDCD1; the disease is melanoma.